Industries > Pharma > Next-Generation Biologics Market Forecast to 2029

Next-Generation Biologics Market Forecast to 2029

Revenue Forecasts and R&D Trends for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine

PUBLISHED: 29 November 2019
PAGES: 296
PRODUCT CODE: PHA0621

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global next-generation biologics market is estimated to have reached $3.2bn in 2018. The market is expected to grow at a CAGR of 19.8% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 296-page report you will receive 181 charts– all unavailable elsewhere.

The 296-page report provides clear detailed insight into the next-generation biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Next-Generation Biologics Market forecast to 2029

• Revenue forecasts for the Next-Generation Biologics Market by Sector to 2029:
• Regenerative Medicine: Stem Cell Therapies, Tissue Engineering, Gene Therapies
• Next-Generation Antibody Therapies: ADC, Engineered Antibodies, Bispecific Antibodies
• Next-Generation Antibody Fragments & ALPs
• Next-Generation Insulin: Oral Insulin, Ultra- Rapid Acting Insulin, Ultra-Long Acting Insulin
• Next-Generation Growth Hormones
• Next-Generation Coagulating Factors
• Others

Next-Generation Biologics Market Forecast to 2029

• Revenue forecasts for the Next-Generation Biologics Market Forecast by Region to 2029:

North America:
• U.S.
• Canada

Europe:
• Germany
• UK
• France
• Italy
• Spain

Asia-Pacific:
• Japan
• China
• India

RoW
• Brazil
• Mexico
• Russia
• South Africa

• Profiles of the selected leading companies:
• AbbVie
• Amgen
• Eli Lilly
• GSK
• Novo Nordisk
• Roche/ Genentech
• Sanofi Aventis
• Seattle Genetics

• The report also includes a STEP Analysis of the Next-Generation Biologics market.

• Key questions answered by this report:
• How is the next-generation biologics therapies market evolving?
• What is driving and restraining the next-generation biologics market?
• What are the market shares of segments of the overall next-generation biologics market in 2018?
• How will each next-generation biologics segment grow over the forecast period and how much revenue will these submarkets account for by 2029?
• How will the market shares for next-generation biologics therapies submarkets develop to 2029?
• Which therapies can succeed and what are their revenue potentials?
• What will be the main sales drivers for the overall market to 2029?
• How will political and regulatory factors influence the regional markets and other submarkets?
• How will the market shares of the regional markets change by 2029 and which geographical region will lead the market by 2029?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the next-generation biologics Market. You find data, trends and predictions.

Buy our report today Next-Generation Biologics Market Forecast to 2029: Revenue Forecasts and R&D Trends for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Biologics Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Next-Generation Biologics Market Forecast to 2029


Latest Pharma news

“Pharmaceutical Contract Manufacturing market set to grow to $138bn by 2024” says Visiongain report

In recent years, one area of biopharmaceutical manufacturing that has come under increasing interest is ADC manufacturing.

16 January 2020

READ

New Advances in the Wound Care Market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal.  …

14 January 2020

READ

Recent Highs & Lows in the Vaccine Market 

With the emergence of new health technology and advances in vaccines, manufacturers and key stakeholders can position themselves to generate big returns in the coming years. However, getting ahead of the competition will require having the right tools at your disposal, which is why Visiongain is proud to offer extensive vaccine market forecasts, as well as reports from other verticals …

14 January 2020

READ

Current Developments in the Global Dermatology Market Pipeline

New trials from around the world are affecting the global dermatology market on an almost daily basis, providing patients with new drugs and medical practitioners with more innovative treatment technology than ever before. That’s why Visiongain has made it their business to help inform key stakeholders and business owners about the most current changes and emerging trends.  Here are a …

14 January 2020

READ

Categories

Category